REGISTER NOW: Community Connect is taking place in Sydney on Saturday 23 March

TSC research trial now recruiting in Australia

Our friends at Sydney Children’s Hospital in Randwick are now recruiting for the TSC-STEPS research trial.

The purpose of this ground-breaking research is to learn more about the safety and efficacy of early sirolimus treatment to prevent or delay seizure onset in infants diagnosed with TSC.  Infants 0 to 6 months old who are diagnosed with TSC and have no history of seizures may be eligible to participate.

If needed, TSA can offer some assistance with travel and accommodation costs for families outside of Sydney, including interstate families who participate in the trial.

2022 STE01464 Recruitment flyer horizontal v1 dated 29 March 2022 1 1 2 pdf

What

The purpose of this research study is to learn more about the safety and efficacy of early sirolimus treatment to prevent or delay seizure onset in infants diagnosed with Tuberous Sclerosis Complex (TSC), a genetic disorder where epilepsy is common.

Who

Infants 0 to 6 months old who are diagnosed with TSC and have no history of seizures may be eligible to participate.

Compensation

There is no compensation for your participation in this study. However, if needed, TSA can offer some assistance with travel and accommodation costs for families outside of Sydney, including interstate families who participate in the trial.

Details

For more information, visit: www.clinicaltrials.gov (identifier NCT05104983)

Or contact:

Dr Denise Chan, [email protected]